Why is Parmax Pharma falling/rising?

As of 16-Jul, Parmax Pharma Ltd's stock price is currently at Rs 40.64, reflecting a decrease of Rs 1.36 or 3.24%. Today, the stock opened with a gain of 7.14%, reaching an intraday high of Rs 45, but subsequently fell to a low of Rs 40.5, indicating high volatility with a wide trading range of Rs 4.5. The stock has underperformed its sector by 2.97% today, and while it has shown positive net sales growth of 98.75% over the last six months, it also has a negative book value and weak long-term fundamentals, which contribute to its current downward trend. Additionally, despite positive results in the last three quarters, the company's ability to service its debt remains weak, and it has generated negative operating profits, further impacting investor sentiment. In the broader market context, Parmax Pharma's short-term performance has been notably worse than the benchmark, with a 1-week return of -3.24% compared to the Sensex's -1.08%. Over the past year, the stock has also underperformed the BSE500, generating a return of -3.24% while the benchmark has increased by 2.38%. This underperformance, combined with the company's weak long-term growth prospects and high volatility, suggests that investor confidence is low, contributing to the stock's decline.